Name

Abiraterone acetate

Alternate Names

CB 7630
CB-7630
CB7630
Zytiga
Yonsa

Abbreviations

AA

Category

Hormones and hormonal mechanisms

Subcategory

Antiandrogenic

NSC Number

None

Primary Site

Prostate

Histology

None

Remarks

April 28, 2011: Zytiga received FDA approval for use in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.

Coding

This drug should be coded
Glossary